The invention relates generally to an occlusion bypassing apparatus and methods of using the apparatus for subintimally bypassing a blockage in a blood vessel such as a chronic total occlusion and reentering the true lumen of the blood vessel beyond the blockage.
Cardiovascular disease, including atherosclerosis, is a serious ailment for many people that may in some cases lead to death. One method for treating atherosclerosis and other forms of arterial lumen narrowing is percutaneous transluminal angioplasty, commonly referred to as “angioplasty” or “PTA,” or “PTCA” when performed in the coronary arteries. The objective in angioplasty is to restore adequate blood flow through the affected artery, which may be accomplished by inflating a balloon of a balloon catheter within the narrowed lumen of the artery to dilate the vessel.
The anatomy of arteries varies widely from patient to patient. Often a patient's arteries are irregularly shaped, highly tortuous and very narrow. The tortuous configuration of the arteries may present difficulties to a clinician in advancement of the balloon catheter to a treatment site. In addition, in some instances, the extent to which the lumen is narrowed at the treatment site is so severe that the lumen is completely or nearly completely obstructed, which may be described as a total occlusion. Total or near-total occlusions in arteries can prevent all or nearly all of the blood flow through the affected arteries. If the occlusion has been established for a long period of time, the lesion may be referred to as a chronic total occlusion or CTO. Chronic total occlusions can occur in coronary as well as peripheral arteries. Chronic total occlusions are often characterized by extensive plaque formation and typically include a fibrous cap surrounding softer plaque material. This fibrous cap may present a surface that is difficult to penetrate with a conventional medical guidewire.
A number of devices have been developed and/or used for the percutaneous interventional treatment of CTOs, such as stiffer guidewires, low-profile balloons, laser light emitting wires, atherectomy devices, drills, drug eluting stents, and re-entry catheters. The factor that is most determinative of whether the physician can successfully recannalize a CTO is the physician's ability to advance a suitable guidewire from a position within the true lumen of the artery proximal to the CTO lesion, across the CTO lesion, i.e., either through the lesion or around it, and then back into the true lumen of the artery at a location distal to the CTO lesion.
In some cases, such as where the artery is totally occluded by hard, calcified atherosclerotic plaque, the guidewire may tend to deviate to one side and penetrate through the intima of the artery, thereby creating a neo-lumen called a “subintimal tract” i.e., a penetration tract formed within the wall of the artery between the intima and adventitia. In these cases, the distal end of the guidewire may be advanced to a position distal to the lesion but remains trapped within the subintimal tract. In such instances, it is then necessary to divert or steer the guidewire from the subintimal tract back into the true lumen of the artery at a location distal to the CTO lesion. The process of manipulating the guidewire to reenter the artery lumen is often difficult and solutions have been proposed utilizing various means for dealing with such a problem.
A number of catheter-based devices have been heretofore useable to redirect subintimally trapped guidewires back into the true lumen of the artery. Included among these are a variety of catheters having laterally deployable cannulae, i.e., hollow needles. For example, some catheter systems utilize a penetrator or needle that, thanks to the presence of an on-board imaging system (IVUS), exits through a side exit port of the catheter to puncture the intimal layer distal of the CTO to re-enter the true lumen of the vessel. A second guidewire is then passed through the laterally deployed needle and is advanced into the true lumen of the artery. However, a need in the art still exists for other medical catheters or systems that consistently and reliably direct subintimally advanced guidewires back into the true lumen of the artery for the treatment of a CTO.
Embodiments hereof are directed to an apparatus for bypassing an occlusion in a blood vessel. The apparatus includes a handle, an outer shaft component, a stabilization tube, and a needle component. The outer shaft component has a side port proximal to a distal end thereof and has a needle lumen there-through that includes a curved distal portion that bends from a longitudinal axis of the apparatus and terminates at the side port of the outer shaft component. A proximal end of the outer shaft component is fixed within the handle at a first attachment point. The stabilization tube has an elongated body extending between a proximal end and a distal end thereof, and the elongated body is disposed within the needle lumen of the outer shaft component. The proximal end of the stabilization tube is fixed within the handle at a second attachment point that is spaced apart from the first attachment point and the elongated body and distal end of the stabilization tube are not attached to the outer shaft component. The needle component is configured to be slidably disposed within the stabilization tube and removable therefrom, and the stabilization tube minimizes resistive forces exerted onto the needle component by the outer shaft component.
In another embodiment hereof, the apparatus includes a handle, an outer shaft component, at least one balloon, a stabilization tube, and a needle component. The outer shaft component has a side port proximal to a distal end thereof and a distal port at the distal end thereof. The outer shaft component includes a needle lumen there-through that includes a curved distal portion that bends from a longitudinal axis of the apparatus and terminates at the side port of the outer shaft component, an inflation lumen there-through for receiving an inflation fluid, and a guidewire lumen that extends along at least a portion of the outer shaft component and terminates at the distal port at the distal end of the outer shaft component. A proximal end of the outer shaft component is fixed within the handle at a first attachment point. The at least one balloon is disposed on the outer shaft component proximal to the distal end thereof, and the balloon is in fluid communication with the inflation lumen of the outer shaft component. The stabilization tube has an elongated body extending between a proximal end and a distal end thereof, and the elongated body is disposed within the needle lumen of the outer shaft component. The proximal end of the stabilization tube is fixed within the handle at a second attachment point that is spaced apart from the first attachment point and the elongated body and distal end of the stabilization tube are not attached to the outer shaft component. The needle component is configured to be slidably disposed within the stabilization tube and removable therefrom, and the stabilization tube minimizes resistive forces exerted onto the needle component by the outer shaft component.
In another embodiment hereof, the apparatus for bypassing an occlusion in a blood vessel includes a handle, an outer shaft component, a stabilization tube, a needle housing, and a needle component. The outer shaft component has a side port proximal to a distal end thereof and includes a needle lumen there-through that includes a curved distal portion that bends from a longitudinal axis of the apparatus and terminates at the side port of the outer shaft component. A proximal end of the outer shaft component is fixed within the handle at a first attachment point. The stabilization tube has an elongated body extending between a proximal end and a distal end thereof, and the elongated body is disposed within the needle lumen of the outer shaft component. The proximal end of the stabilization tube is fixed within the handle at a second attachment point that is spaced apart from the first attachment point and the elongated body and distal end of the stabilization tube are not attached to the outer shaft component. The needle housing is disposed within the needle lumen of the outer shaft component. The needle housing includes a curved distal portion that defines the curved distal portion of the needle lumen and a transition proximal portion that has a variable flexibility along its length that decreases in a distal direction. The distal end of the stabilization tube is proximal to a proximal end of the needle housing. The needle component is configured to be slidably disposed within the stabilization tube and removable therefrom. The needle component has a curved distal end with the same curvature as the curved distal portion of the needle lumen of the outer shaft component and a distal tip configured to penetrate a wall of the vessel. In a first configuration of the apparatus, the curved distal end of the needle component is held in a straightened form within the needle housing. In a second configuration of the apparatus, the curved distal end of the needle component extends from the side port of the outer shaft component and bends from the longitudinal axis of the apparatus.
The foregoing and other features and advantages of the invention will be apparent from the following description of embodiments hereof as illustrated in the accompanying drawings. The accompanying drawings, which are incorporated herein and form a part of the specification, further serve to explain the principles of the invention and to enable a person skilled in the pertinent art to make and use the invention. The drawings are not to scale.
Specific embodiments of the present invention are now described with reference to the figures, wherein like reference numbers indicate identical or functionally similar elements. The terms “distal” and “proximal” are used in the following description with respect to a position or direction relative to the treating clinician. “Distal” or “distally” are a position distant from or in a direction away from the clinician. “Proximal” and “proximally” are a position near or in a direction toward the clinician.
The following detailed description is merely exemplary in nature and is not intended to limit the invention or the application and uses of the invention. Although the description of the invention is in the context of treatment of blood vessels such as smaller diameter peripheral or coronary arteries, the invention may also be used in any other body passageways where it is deemed useful. Although the description of the invention generally refers to an apparatus and method of bypassing a vessel blockage in a proximal-to-distal direction, i.e. antegrade or with the blood flow, the invention may be used equally well to bypass a vessel blockage in a distal-to-proximal direction, i.e. retrograde or against the blood flow, if access is available from that direction. In other terms, the apparatus and method described herein may be considered to bypass a vessel blockage from a near side of the blockage to a far side of the blockage. Furthermore, there is no intention to be bound by any expressed or implied theory presented in the preceding technical field, background, brief summary or the following detailed description.
Embodiments hereof relate to an apparatus and method for re-entering the true lumen of a vessel after subintimally bypassing an occlusion in a blood vessel such as a chronic total occlusion (CTO) of an artery. The apparatus includes a handle, an outer shaft component, a stabilization tube which is disposed within the outer shaft component, and a needle component which is configured to be slidably disposed within the stabilization tube and removable therefrom. The stabilization tube minimizes or eliminates resistive forces exerted onto the needle component by the outer shaft component. More particularly, the outer shaft component and the stabilization tube are fixed within the handle at spaced apart attachment or fixation points so that the stabilization tube essentially hides the resistance exerted by the advancement of the needle component to the outer shaft component. Without the stabilization tube, friction or resistive force exists between the needle component and the outer shaft component while the needle component is deployed, and such resistive force tends to elongate the outer shaft component and jeopardizes the overall performance of the apparatus. However, with the stabilization tube, such resistive force remains almost completely within the stabilization tube, thus preventing the outer shaft component from being exposed to such force or stress and thus preserving the overall performance of the apparatus.
More particularly, with reference to the figures,
Outer shaft component 102 includes a first lateral balloon 122A and a second lateral balloon 122B mounted on a distal portion thereof. A flexible distal tip 126 is coupled to distal end 106 of outer shaft component 102. As best shown on the top view of
Guidewire lumen 129 is relatively short and extends only through a distal portion of outer shaft component 102 for accommodating guidewire 140 in a so-called rapid-exchange configuration. More particularly, guidewire lumen 129 extends from a proximal guidewire port 130 (see
Outer shaft component 102 may be formed of one or more polymeric materials, non-exhaustive examples of which include polyethylene, polyethylene block amide copolymer (PEBA), polyamide and/or combinations thereof, either laminated, blended or co-extruded. Optionally, outer shaft component 102 or some portion thereof may be formed as a composite having a reinforcement layer incorporated within a polymeric body in order to enhance strength and/or flexibility and/or torquability. Suitable reinforcement layers include braiding, wire mesh layers, embedded axial wires, embedded helical or circumferential wires, hypotubes, and the like. In one embodiment, for example, at least a proximal portion of outer shaft component 102 may be formed from a reinforced polymeric tube.
Other types of construction are suitable for outer shaft component 102. In another embodiment (not shown), rather than a single inflation lumen that concurrently delivers inflation fluid to both first and second lateral balloons 122A, 122B as described herein, the outer shaft component may include two inflation lumens that separately deliver inflation fluid to the first and second lateral balloons. Further, although embodiments above are described with a relatively short guidewire lumen in a rapid-exchange configuration, embodiments hereof may be modified to have an over-the-wire configuration in which the guidewire lumen extends the entire length of the outer shaft component. For example, in order to provide an over-the-wire configuration, the relatively short guidewire lumen of the above embodiment may be modified to extend the entire length of the outer shaft component.
As stated above, needle lumen 109 of outer shaft component 102 houses stabilization tube 110 and needle housing 116. More particularly, stabilization tube 110 and needle housing 116 are separate or distinct components that lay within needle lumen 109 of outer shaft component 102. Stabilization tube 110 and needle housing 116 are disposed within longitudinally spaced-apart locations of needle lumen 109 of outer shaft component 102. Stabilization tube 110 is positioned proximal to needle housing 116, which is disposed at a distal portion of needle lumen 109 of outer shaft component 102. Accordingly, with reference back to
Stabilization tube 110 is a tubular or cylindrical shaft component that includes an elongated body portion 114 that extends substantially parallel with a longitudinal axis LA of occlusion bypassing apparatus 100. Stabilization tube 110 defines a lumen 112 that extends from a proximal end 111 to distal end 115 thereof, with lumen 112 being sized and configured to slidably and removably receive needle component 134 there-through. As will be described in more detail herein, needle housing 116 is a tubular or cylindrical shaft component that includes a proximal transition portion 118 with a variable flexibility and a curved distal portion 120. Needle housing 116 is disposed at the distal portion of needle lumen 109, with proximal end 117 being embedded into or expanded into apposition with the polymeric material of outer shaft component 102. Curved distal portion 120 of needle housing 116 bends from longitudinal axis LA of occlusion bypassing apparatus 100 and terminates at side port 108 of outer shaft component 102. Needle housing 116 defines a lumen 127 that extends from proximal end 117 to a distal end 113 thereof, with lumen 127 also being sized and configured to slidably and removably receive needle component 134 there-through. When needle component 134 is positioned within occlusion bypassing apparatus 100, needle component 134 is disposed or extends through lumen 112 of stabilization tube 110, through lumen 109 of outer shaft component 102 along gap 119 between stabilization tube 110 and needle housing 116, and through lumen 127 of needle housing 116.
In an embodiment hereof, stabilization tube 110 is an elongate polymeric tube while needle housing 116 is a metallic tube of a relatively shorter length than the length of stabilization tube 110 with needle housing 116 being less flexible or stiffer than stabilization tube 110. Typically, the needle housing length is about 2-5% of the stabilization tube length. Thus, stabilization tube 110 surrounds needle component 134 for the majority of its length and prevents contact between needle component 134 and outer shaft component 102. For example, stabilization tube 110 may be a polymeric tube formed of a flexible polymeric material, non-exhaustive examples of which include polyethylene, polyethylene block amide copolymer (PEBA), polyamide and/or combinations thereof. Polymeric material ensures that stabilization tube 110, and thus occlusion bypassing apparatus 100, has the required flexibility necessary for in situ delivery. Needle housing 116 is preferably formed from a shape memory material such as nitinol to ensure high flexibility of occlusion bypassing apparatus 100 during advancement through the vasculature. Alternatively, needle housing 116 may be formed from a metallic resilient material such as steel or spring temper stainless steel.
As best shown on
More particularly, the function of stabilization tube 110 is illustrated in the schematic views of
With reference to
With reference now to
Referring back to
In order to smooth or bridge the transition between flexible stabilization tube 110 and relatively stiffer or less flexible needle housing 116, needle housing 116 includes proximal transition portion 118. Transition portion 118 has a variable flexibility along its length that decreases in a distal direction as indicated by directional arrow 121 (see
In order to provide transition portion 118 of needle housing 116 with varying flexibility, transition portion 118 includes a plurality of apertures 142, wherein pairs of apertures align with each other along a respective transverse axis of needle housing 116. Each aperture is a cut-out portion or window that increases the flexibility of transition portion 118 as compared to the remaining length of needle housing 118, i.e., straightening portion 123 of needle housing 116 and curved distal portion 120 which have no apertures or cut-out portions formed therein. As used herein, any respective pair of aligned apertures may be referred to singularly or collectively as a pair or pairs of aligned apertures 142. Although shown with seven pairs of aligned apertures 142, a greater or lesser number of pairs of aligned apertures 142 may be used to provide transition portion 118 with varying flexibility. As further described in U.S. patent application Ser. No. 14/460,068 to Guala et al, filed Aug. 14, 2014, which is herein incorporated by reference in its entirety, each aperture in a pair of aligned apertures 142 has an hourglass shape and is disposed from the other aperture of the pair on an opposite side of the perimeter or outer surface of needle housing 116 so as to be diametrically opposed thereto. In order to provide transition portion 118 with varying flexibility along its length that decreases in a distal direction, the pitch or spacing between adjacent pairs of aligned apertures increases in a distal direction. The distance or spacing between adjacent pairs of aligned apertures 142 continues to increase such that distance or spacing between the most distal apertures is the greatest. Since a greater amount of metallic material extends between consecutive pairs of aligned apertures 142, gradually increasing the pitch or spacing between axially adjacent pairs of aligned apertures 142 in the distal direction results in a gradual decrease of flexibility in the distal direction. In addition or in the alternative to varying the spacing between adjacent pairs of aligned apertures 142, in another embodiment the size or area of adjacent pairs of aligned apertures 142 may be varied in order to result in a gradual decrease of flexibility along the length of transition portion 118 in the distal direction as further described in U.S. patent application Ser. No. 14/460,068 to Guala et al, filed Aug. 14, 2014, previously incorporated by reference.
Needle component 134, which is shown removed from occlusion bypassing apparatus 100 in
Needle component 134 includes an elongated first or proximal segment 138 that extends substantially parallel with longitudinal axis LA of occlusion bypassing apparatus 100 and curved distal end 136 distally extending from a distal end of proximal segment 138. Curved distal end 136 is pre-formed in a bent or curved shape or configuration. More particularly, as shown in
With reference now to
In the sectional view of
Prior to use of occlusion bypassing apparatus 100 within the vasculature, it may be desirable to flush the apparatus in accordance with techniques known in the field of interventional cardiology and/or interventional radiology. Flushing of occlusion bypassing apparatus 100 may be performed through lumen 135 of needle component 134. More particularly, small openings or holes (not shown) may be provided on needle component 134. In order to perform the initial flushing of occlusion bypassing apparatus 100, side port 108 of outer shaft component 102 is occluded. Saline solution is introduced into a proximal end of lumen 135 of needle component 134 and flushes lumen 135. Since side port 108 is occluded, the saline solution exits from the small holes formed on needle component 134 and flushes lumen 112 of stabilization tube 110 and lumen 127 of needle housing 116.
As shown in
Alternatively, another device other than guidewire 140 initially may be used to create the subintimal tract. Those of ordinary skill in the art will appreciate and understand the types of alternative devices that may be used in this step including an apparatus known as an “olive”, a laser wire, an elongate radiofrequency electrode, a microcatheter, or any other device suitable for boring or advancing through the vessel tissue. As another example, a guidewire other than guidewire 140 may be utilized to create the subintimal tract. More particularly, a guidewire having a relatively larger outer diameter than guidewire 140, such as between 0.032-0.040 inches, may be utilized to create the subintimal tract because a larger guidewire has greater column strength to gain access to the subintimal space of vessel V. If an alternative device is used instead of guidewire 140 to form the subintimal tract, such alternative device may be removed and replaced with guidewire 140 after the subintimal tract has been formed.
After the subintimal tract is formed and guidewire 140 is in place as desired, occlusion bypassing apparatus 100 may be tracked over guidewire 140 and advanced such that distal tip 126 is adjacent to the far or downstream end of occlusion O as shown in
Once outer shaft component 102 is positioned as desired, lateral balloons 122A, 122B may be expanded or inflated as shown in
With reference to
A second guidewire 1570 may be advanced through lumen 135 of needle component 134 and into the true lumen TL of vessel V as shown in
Additionally, a covered or uncovered stent may be delivered over guidewire 1570 and implanted within the subintimal tract to facilitate flow from the lumen of the vessel upstream of the CTO, through the subintimal tract and back into the lumen of the vessel downstream of the CTO.
While various embodiments according to the present invention have been described above, it should be understood that they have been presented by way of illustration and example only, and not limitation. It will be apparent to persons skilled in the relevant art that various changes in form and detail can be made therein without departing from the spirit and scope of the invention. Thus, the breadth and scope of the present invention should not be limited by any of the above-described exemplary embodiments, but should be defined only in accordance with the appended claims and their equivalents. It will also be understood that each feature of each embodiment discussed herein, and of each reference cited herein, can be used in combination with the features of any other embodiment. All patents and publications discussed herein are incorporated by reference herein in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
3568659 | Karnegia | Mar 1971 | A |
4552554 | Gould et al. | Nov 1985 | A |
4774949 | Fogarty | Oct 1988 | A |
5002532 | Gaiser et al. | Mar 1991 | A |
5250069 | Nobuyoshi | Oct 1993 | A |
5460608 | Lodin et al. | Oct 1995 | A |
5501667 | Verduin, Jr. | Mar 1996 | A |
5569184 | Crocker et al. | Oct 1996 | A |
5599324 | McAlister | Feb 1997 | A |
5667493 | Janacek | Sep 1997 | A |
5707389 | Louw et al. | Jan 1998 | A |
5830222 | Makower | Nov 1998 | A |
5916194 | Jacobsen et al. | Jun 1999 | A |
5947994 | Louw et al. | Sep 1999 | A |
6068638 | Makower | May 2000 | A |
6071292 | Makower et al. | Jun 2000 | A |
6081738 | Hinohara et al. | Jun 2000 | A |
6159225 | Makower | Dec 2000 | A |
6178968 | Louw et al. | Jan 2001 | B1 |
6190353 | Makower et al. | Feb 2001 | B1 |
6196230 | Hall | Mar 2001 | B1 |
6203524 | Burney et al. | Mar 2001 | B1 |
6210377 | Ouchi | Apr 2001 | B1 |
6217527 | Selmon et al. | Apr 2001 | B1 |
6221049 | Selmon et al. | Apr 2001 | B1 |
6231546 | Milo et al. | May 2001 | B1 |
6231563 | White et al. | May 2001 | B1 |
6231587 | Makower et al. | May 2001 | B1 |
6235000 | Milo et al. | May 2001 | B1 |
6261260 | Maki et al. | Jul 2001 | B1 |
6283983 | Makower et al. | Sep 2001 | B1 |
6287317 | Makower et al. | Sep 2001 | B1 |
6302875 | Makower et al. | Oct 2001 | B1 |
6355027 | Le et al. | Mar 2002 | B1 |
6375615 | Makower et al. | Apr 2002 | B1 |
6379319 | Garibotto et al. | Apr 2002 | B1 |
6432127 | Kim et al. | Aug 2002 | B1 |
6447477 | Burney et al. | Sep 2002 | B2 |
6458098 | Kanesaka | Oct 2002 | B1 |
6508824 | Flaherty et al. | Jan 2003 | B1 |
6511458 | Milo et al. | Jan 2003 | B2 |
6514217 | Selmon et al. | Feb 2003 | B1 |
6514228 | Hamilton et al. | Feb 2003 | B1 |
6544230 | Flaherty | Apr 2003 | B1 |
6579311 | Makower | Jun 2003 | B1 |
6602241 | Makower et al. | Aug 2003 | B2 |
6655386 | Makower et al. | Dec 2003 | B1 |
6669709 | Cohn et al. | Dec 2003 | B1 |
6709444 | Makower | Mar 2004 | B1 |
6719725 | Milo et al. | Apr 2004 | B2 |
6726677 | Makower et al. | Apr 2004 | B1 |
6746464 | Makower et al. | Jun 2004 | B1 |
7004173 | Sparks et al. | Feb 2006 | B2 |
7059330 | Makower et al. | Jun 2006 | B1 |
7066914 | Andersen | Jun 2006 | B2 |
7141041 | Seward | Nov 2006 | B2 |
7179270 | Makower et al. | Feb 2007 | B2 |
7316655 | Garibotto et al. | Jan 2008 | B2 |
7357794 | Makower et al. | Apr 2008 | B2 |
7534223 | Boutilette et al. | May 2009 | B2 |
7606615 | Makower et al. | Oct 2009 | B2 |
7637870 | Flaherty et al. | Dec 2009 | B2 |
7729738 | Flaherty et al. | Jun 2010 | B2 |
7762985 | Kabrick et al. | Jul 2010 | B2 |
7833197 | Boutilette et al. | Nov 2010 | B2 |
7854727 | Belsley | Dec 2010 | B2 |
RE42049 | Schroeder et al. | Jan 2011 | E |
7878986 | Jen et al. | Feb 2011 | B2 |
7938819 | Kugler et al. | May 2011 | B2 |
8083727 | Kugler et al. | Dec 2011 | B2 |
8172863 | Robinson et al. | May 2012 | B2 |
8202246 | Kugler et al. | Jun 2012 | B2 |
8221357 | Boutillette | Jul 2012 | B2 |
8226566 | Nita | Jul 2012 | B2 |
8241311 | Ward et al. | Aug 2012 | B2 |
8257382 | Rottenberg et al. | Sep 2012 | B2 |
8323261 | Kugler et al. | Dec 2012 | B2 |
8337425 | Olson et al. | Dec 2012 | B2 |
8388876 | Boutilette et al. | Mar 2013 | B2 |
8460254 | Belsley | Jun 2013 | B2 |
8486022 | Ludwig et al. | Jul 2013 | B2 |
8496679 | Robinson et al. | Jul 2013 | B2 |
8512310 | Kugler et al. | Aug 2013 | B2 |
8535245 | Jen et al. | Sep 2013 | B2 |
8556857 | Boutillette | Oct 2013 | B2 |
9060802 | Kugler | Jun 2015 | B2 |
9095374 | Piccagli | Aug 2015 | B2 |
20010000041 | Selmon et al. | Mar 2001 | A1 |
20020072706 | Hiblar et al. | Jun 2002 | A1 |
20030163154 | Miyata et al. | Aug 2003 | A1 |
20040073165 | Musbach et al. | Apr 2004 | A1 |
20040167554 | Simpson et al. | Aug 2004 | A1 |
20040186506 | Simpson et al. | Sep 2004 | A1 |
20050021003 | Caso et al. | Jan 2005 | A1 |
20050149062 | Carroll | Jul 2005 | A1 |
20050159728 | Armour et al. | Jul 2005 | A1 |
20050171478 | Selmon et al. | Aug 2005 | A1 |
20050267459 | Belhe et al. | Dec 2005 | A1 |
20060074442 | Noriega et al. | Apr 2006 | A1 |
20060094930 | Sparks et al. | May 2006 | A1 |
20060241564 | Corcoran et al. | Oct 2006 | A1 |
20060276749 | Selmon et al. | Dec 2006 | A1 |
20070123925 | Benjamin et al. | May 2007 | A1 |
20080125748 | Patel | May 2008 | A1 |
20080140101 | Carley et al. | Jun 2008 | A1 |
20080147000 | Seibel et al. | Jun 2008 | A1 |
20080249464 | Spencer et al. | Oct 2008 | A1 |
20090124899 | Jacobs et al. | May 2009 | A1 |
20090192584 | Gerdts | Jul 2009 | A1 |
20090209910 | Kugler et al. | Aug 2009 | A1 |
20100010522 | Shturman | Jan 2010 | A1 |
20100063534 | Kugler et al. | Mar 2010 | A1 |
20110144677 | Ward et al. | Jun 2011 | A1 |
20110264125 | Wilson et al. | Oct 2011 | A1 |
20110276079 | Kugler et al. | Nov 2011 | A1 |
20120053485 | Bloom | Mar 2012 | A1 |
20120095485 | Cully et al. | Apr 2012 | A1 |
20120283571 | Nita | Nov 2012 | A1 |
20120283761 | Rosenthal et al. | Nov 2012 | A1 |
20120323220 | Mackay, II | Dec 2012 | A1 |
20120323251 | Kugler et al. | Dec 2012 | A1 |
20120323269 | Rottenberg et al. | Dec 2012 | A1 |
20130006167 | Alvarez | Jan 2013 | A1 |
20130006173 | Alvarez et al. | Jan 2013 | A1 |
20130006282 | Wilkinson | Jan 2013 | A1 |
20130072957 | Anderson | Mar 2013 | A1 |
20130103070 | Kugler et al. | Apr 2013 | A1 |
20130116622 | Takagi | May 2013 | A1 |
20130150880 | Anderson | Jun 2013 | A1 |
20130158519 | Boutilette et al. | Jun 2013 | A1 |
20130245430 | Selmon et al. | Sep 2013 | A1 |
20130261545 | Osypka | Oct 2013 | A1 |
20130296907 | Robinson et al. | Nov 2013 | A1 |
20130304108 | Weber et al. | Nov 2013 | A1 |
20130310868 | Kugler et al. | Nov 2013 | A1 |
20130317528 | Anderson et al. | Nov 2013 | A1 |
20140018732 | Bagaoisan et al. | Jan 2014 | A1 |
20140142607 | Cage | May 2014 | A1 |
20140214057 | Piccagli | Jul 2014 | A1 |
20140277053 | Wang et al. | Sep 2014 | A1 |
20150174371 | Schaeffer | Jun 2015 | A1 |
Number | Date | Country |
---|---|---|
1765193 | Oct 2012 | EP |
WO2006105244 | Oct 2006 | WO |
WO2008120209 | Oct 2008 | WO |
WO2009144561 | Dec 2009 | WO |
WO2013003757 | Jan 2013 | WO |
WO2013164825 | Nov 2013 | WO |
WO2014039096 | Mar 2014 | WO |
Entry |
---|
U.S. Appl. No. 13/952,973, filed Jul. 29, 2013, Silvestro. |
U.S. Appl. No. 13/952,981, filed Jul. 29, 2013, Silvestro. |
U.S. Appl. No. 14/197,803, filed Mar. 5, 2014, Silvestro. |
U.S. Appl. No. 14/058,444, filed Oct. 21, 2013, Silvestro. |
Shin et al. “Limitations of the Outback LTD re-entry device in femoropopliteal chronic total occlusions.” Journal of Vascular Surgery, vol. 53, 5; 2010. |
A. Bolia “Subintimial Angioplasty, the Way Forward” Acta chir belg, 2004, 104, 547-554. |
Karkos et al. “Subintimal Recanalization of the Femoropopliteal Segment to Promote Healing of an Ulcerated Below-Knee Amputation Stump” J Endovasc Ther 2006;13:420-423. |
Glasby et al. “Subintimal Angioplasty” Review, pp. 12-16, 2008. |
Bolia A. “Subintimal Angioplasty, Tips and Technique: How Long Can You Go?”. |
International Search Report dated Jan. 5, 2017 in corresponding International Patent Application No. PCT/US2016/051827. |
Written Opinion dated Jan. 5, 2017 in corresponding International Patent Application No. PCT/US2016/051827. |
Number | Date | Country | |
---|---|---|---|
20170079671 A1 | Mar 2017 | US |